Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Cardioprotective treatment during adjuvant cancer therapy].
Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T. Gulati G, et al. Among authors: ree ah. Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1832-6. doi: 10.4045/tidsskr.12.1514. Tidsskr Nor Laegeforen. 2013. PMID: 24042297 Free article. Review. Norwegian.
[Molecular targeted therapy in colorectal cancer].
Ree AH, Bratland A, Dueland S. Ree AH, et al. Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):190-3. Tidsskr Nor Laegeforen. 2008. PMID: 18202731 Free article. Review. Norwegian.
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T. Gulati G, et al. Among authors: ree ah. J Am Heart Assoc. 2017 Nov 8;6(11):e006513. doi: 10.1161/JAHA.117.006513. J Am Heart Assoc. 2017. PMID: 29118031 Free PMC article. Clinical Trial.
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T. Gulati G, et al. Among authors: ree ah. Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21. Eur Heart J. 2016. PMID: 26903532 Free PMC article. Clinical Trial.
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol.
Heck SL, Mecinaj A, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, Røsjø H, Steine K, Geisler J, Gulati G, Omland T. Heck SL, et al. Among authors: ree ah. Circulation. 2021 Jun 22;143(25):2431-2440. doi: 10.1161/CIRCULATIONAHA.121.054698. Epub 2021 May 16. Circulation. 2021. PMID: 33993702 Free PMC article. Clinical Trial.
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.
Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T. Heck SL, et al. Among authors: ree ah. Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):544-552. doi: 10.1093/ehjci/jex159. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29106497 Clinical Trial.
Immune-modulating cancer therapy - back to the future.
Ree AH. Ree AH. Tidsskr Nor Laegeforen. 2016 Oct 25;136(19):1605. doi: 10.4045/tidsskr.16.0630. eCollection 2016 Oct. Tidsskr Nor Laegeforen. 2016. PMID: 27790877 Free article. English, Norwegian. No abstract available.
144 results